News

LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that […]

SAN DIEGO–(BUSINESS WIRE)—- $JANX–Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor Activated T Cell Engager (TRACTr), Tumor Activated […]

SAN DIEGO–(BUSINESS WIRE)–Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2025, […]

SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company or Cidara), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today reported financial results […]

SAN DIEGO–(BUSINESS WIRE)–Physicians and researchers from Ivy Fertility, a globally-recognized network of fertility centers, shared cutting-edge presentations and posters at the 2025 American Society for Reproductive Medicine (ASRM) Conference in San Antonio, Texas last week. […]

SAN DIEGO–(BUSINESS WIRE)– #B2B–Scientist.com takes home Supplier Management Excellence Award at B2B Ecommerce Awards for supplier network innovation, integration, and performance. Click here to view original post Click Here to Publish/Feature Your Company or Product […]

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced new long-term data for DAWNZERA™ (donidalorsen), the first and only RNA-targeted prophylactic medicine for hereditary angioedema (HAE), to be presented at the 2025 American College of […]

CARLSBAD, Calif.–(BUSINESS WIRE)– #ArimaGenomics–Arima Genomics has been named the winner of the BioTech Breakthrough Award for “Clinical Diagnostics Solution of the Year.” Click here to view original post Click Here to Publish/Feature Your Company or […]

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the third quarter ended September 30, 2025. “Acadia delivered another strong quarter, generating total revenue of $278.6 million,” said Catherine Owen Adams, […]

FOSTER CITY, Calif.–(BUSINESS WIRE)–Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, today emerged from stealth with $6.7 million in seed funding led […]

SAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on advancing new therapeutic pathways for obesity and other metabolic health disorders, will host a conference call […]

SAN DIEGO, Nov. 05, 2025 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today […]

TAMPA, Fla.–(BUSINESS WIRE)–Catalent, Inc. presented new advancements in its SMARTag® antibody-drug conjugate (ADC) technology at the 16th World ADC San Diego conference. Click here to view original post Click Here to Publish/Feature Your Company or […]

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the third quarter ended September 30, 2025, and […]